Welcome to our dedicated page for Alignment Healthcare news (Ticker: ALHC), a resource for investors and traders seeking the latest updates and insights on Alignment Healthcare stock.
Alignment Healthcare, Inc. (NASDAQ: ALHC) delivers innovative Medicare Advantage solutions through its consumer-focused care model and integrated technology platform. This news hub provides investors and healthcare professionals with essential updates about the company's operational developments and market position.
Access real-time announcements including earnings reports, partnership agreements, service expansions, and regulatory filings. Our curated collection enables stakeholders to track ALHC's progress in enhancing senior care through clinical coordination and data-driven solutions.
Key updates cover Medicare Advantage plan developments, technology platform enhancements, and strategic provider partnerships. Users will find authoritative information about care delivery innovations and financial performance indicators without speculative commentary.
Bookmark this page for continuous access to verified ALHC announcements and analysis. Monitor the company's advancements in reducing healthcare inefficiencies while improving outcomes for chronically ill seniors through its unique care coordination model.
Alignment Healthcare (NASDAQ: ALHC) reported strong Q2 2025 financial results, surpassing guidance across all key metrics. The company achieved total revenue of $1.0 billion, up 49.0% year-over-year, and grew its health plan membership to 223,700 members, a 27.8% increase. Notable Q2 metrics include adjusted gross profit of $135.2 million, net income of $15.7 million, and adjusted EBITDA of $45.9 million.
The company demonstrated strong operational performance with a medical benefits ratio of 86.7% and raised its full-year 2025 outlook. For Q3 2025, ALHC projects membership between 225,000-227,000 and revenue of $970-985 million. The full-year 2025 guidance was increased to revenue of $3.885-3.910 billion and adjusted EBITDA of $69-83 million.
[ "Revenue grew significantly by 49.0% year-over-year to $1.0 billion", "Health plan membership increased 27.8% year-over-year to 223,700 members", "Achieved profitability with net income of $15.7 million, compared to loss in previous year", "Adjusted EBITDA improved substantially to $45.9 million from $6.0 million year-over-year", "Raised full-year guidance across all key metrics" ]Alignment Healthcare (NASDAQ: ALHC) has released its 2024 Impact Report, highlighting significant improvements in senior healthcare delivery. The company achieved 100% enrollment in 4-star or higher-rated plans, up from 90% in 2023, while maintaining an impressive Net Promoter Score of 61, well above the industry average of 40.
Key achievements include a 35% increase in Care Anywhere program membership to 11,500 members, a 95% year-over-year increase in ACCESS card transactions to 3.1 million, and an 86% expansion in caregiver benefit access. The company reported its lowest hospitalization rate to date at 149 per 1,000 members, a 4.5% improvement from 2023, and achieved 47% fewer skilled nursing facility admissions compared to the 2019 Medicare benchmark.
Alignment Healthcare (NASDAQ: ALHC) has scheduled its second quarter 2025 financial results announcement for Wednesday, July 30, 2025, after market close. The company will host a conference call at 5 p.m. EDT to discuss the results.
Investors can access the live audio webcast through the company's investor relations website at ir.alignmenthealth.com. A replay of the call will be available for approximately 12 months following the event.
Alignment Healthcare (NASDAQ: ALHC) secured a significant legal victory against CMS, resulting in the elevation of its Arizona HMO 2025 star rating from 3.5 to 4 stars. Following this court ruling on June 9, 100% of Alignment's Medicare Advantage members are now enrolled in plans rated 4 stars or higher.
The company serves approximately 217,500 Medicare beneficiaries across five states: Arizona, California, Nevada, North Carolina, and Texas. The upgraded rating qualifies Alignment for CMS bonus payments, which will be reinvested to enhance member benefits and services. The company maintains a 4.9 out of 5-star Google rating and was recognized as a Newsweek World's Most Trustworthy Company 2024.
Alignment Healthcare (NASDAQ: ALHC) has announced its participation in the upcoming William Blair 45th Annual Growth Stock Conference. The company's presentation is scheduled for Wednesday, June 4, at 2 p.m. CDT. Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
Alignment Healthcare (NASDAQ: ALHC) has received the 2025 PQA Laura Cranston Excellence in Quality Award for its Medicare Advantage prescription drug (MAPD) plan. The company was one of only two MAPD plans out of 633 eligible contracts to achieve this recognition, representing the top 1.3%. The award requires a minimum 4.5-star Part D summary rating and a perfect 5-star rating on all five PQA medication measures used in CMS's star ratings program.
The recognition marks Alignment's sixth time receiving this honor, having previously won the PQA Excellence in Quality Award from 2018 to 2022. The company achieved perfect ratings in medication adherence for diabetes, hypertension, and cholesterol medications, as well as in medication therapy management program completion and statin use in persons with diabetes.
Alignment Healthcare (NASDAQ: ALHC) has announced its upcoming participation at the BofA Securities Healthcare Conference. The presentation is scheduled for Wednesday, May 14, at 2:20 p.m. PDT.
Interested parties can access both the live webcast and replay of the presentation through Alignment's investor relations website at https://ir.alignmenthealth.com/.
FAQ
What is the current stock price of Alignment Healthcare (ALHC)?
What is the market cap of Alignment Healthcare (ALHC)?
